Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

188
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
188
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

557
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
557
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

197
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
197

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chinese Clinical Named Entity Recognition From Electronic Medical Records Based on Multisemantic Features by Using Robustly Optimized Bidirectional Encoder Representation From Transformers Pretraining Approach Whole Word Masking and Convolutional Neural Networks: Model Development and Validation.

JMIR medical informatics·2023
Same author

Head and Tail Entity Fusion Model in Medical Knowledge Graph Construction: Case Study for Pituitary Adenoma.

JMIR medical informatics·2021
Same author

Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study.

Journal of medical Internet research·2020
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

610

Interpretable Machine Learning Model for Predicting and Assessing the Risk of Diabetic Nephropathy: Prediction Model

Yili Wen1, Zhiqiang Wan2, Huiling Ren1

  • 1Institute of Medical Information/Medical Library, Chinese Academy of Medical Sciences & Peking Union Medical College, 3 Yabao Road, Chaoyang District, Beijing, 100010, China, 86 01052328911.

JMIR Medical Informatics
|October 22, 2025
PubMed
Summary

A new machine learning model accurately predicts diabetic nephropathy (DN) in type 2 diabetes patients. This interpretable tool aids early diagnosis and personalized treatment, improving patient outcomes.

Keywords:
MLML modeldiabetesdiabetic nephropathyearly diagnosisfibrosisglucosehypertensioninflammationinterpretability analysiskidneymachine learningoxidative stresspatient outcomespredictive toolquality of liferenal diseaserenal functionrisk assessmenttype 2 diabetes

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K

Related Experiment Videos

Last Updated: Jan 14, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

610
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K

Area of Science:

  • Nephrology
  • Artificial Intelligence
  • Data Science

Background:

  • Diabetic nephropathy (DN) affects 30-40% of diabetes patients, leading to kidney failure.
  • Current diagnostic methods for DN lack sensitivity and specificity for early detection.
  • Accurate, interpretable predictive models are crucial for timely intervention and improved patient care.

Purpose of the Study:

  • Develop and validate a machine learning (ML) model for predicting DN in type 2 diabetes patients.
  • Enhance model transparency and interpretability using explainable AI (XAI) techniques.
  • Support early DN diagnosis, risk stratification, and personalized clinical decision-making.

Main Methods:

  • Retrospective cohort study of 1000 type 2 diabetes patients (2015-2020).
  • Utilized Extreme Gradient Boosting (XGBoost), CatBoost, and Light Gradient-Boosting Machine (LightGBM) algorithms.
  • Applied Local Interpretable Model-Agnostic Explanations (LIME) and Shapley Additive Explanations (SHAP) for interpretability.

Main Results:

  • XGBoost and LightGBM showed superior performance in predicting DN.
  • XGBoost achieved 86.87% accuracy, 88.90% precision, 84.40% recall, and 89.12% specificity.
  • Serum creatinine, albumin, and lipoproteins identified as key predictors through LIME and SHAP analyses.

Conclusions:

  • The developed ML model offers a robust and interpretable tool for early DN detection and risk assessment.
  • The model's transparency is vital for clinical integration and trust.
  • Potential to improve patient outcomes and optimize healthcare resource allocation through early intervention.